Trials / Conditions / Rectal Cancer Stage II

Rectal Cancer Stage II

15 registered clinical trials studyying Rectal Cancer Stage II — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial NCT06802172	Fred Hutchinson Cancer Center	N/A
Not Yet Recruiting	Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression NCT07176182	Sixth Affiliated Hospital, Sun Yat-sen University	Phase 2
Not Yet Recruiting	Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Canc NCT07397442	Beijing Friendship Hospital	Phase 2
Not Yet Recruiting	Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer NCT06823297	Turkish Society of Colon and Rectal Surgery	—
Recruiting	The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Underg NCT06565052	Dana-Farber Cancer Institute	N/A
Recruiting	ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer NCT06589388	Gene Solutions	—
Recruiting	The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer NCT06254521	First Affiliated Hospital of Guangxi Medical University	Phase 2
Completed	"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Patholo NCT05495308	Hospital San Carlos, Madrid	—
Active Not Recruiting	Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Can NCT04503694	Jules Bordet Institute	Phase 2
Unknown	Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer NCT04970498	Peking University Third Hospital	—
Active Not Recruiting	TNT to Increase the Clinical Complete Response Rate for Distal LARC NCT03840239	Sun Yat-sen University	Phase 2
Completed	Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Ge NCT03602079	Klus Pharma Inc.	Phase 1 / Phase 2
Unknown	Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemothera NCT03561142	University Hospital Tuebingen	Phase 2
Completed	Induction Chemotherapy Before or After Preoperative Chemoradiotherapy and Surgery for Locally Advanced Rectal NCT02363374	Prof. Dr. med. Claus Rödel	Phase 2
Completed	Optimal Surgery and MRI Based Radiochemotherapy in Rectal Carcinoma NCT01325649	Johannes Gutenberg University Mainz	—